Tumor-promoting effects of pancreatic cancer cell exosomes on THP-1-derived macrophages
暂无分享,去创建一个
T. Abraham | J. Liao | P. Butler | M. Kester | G. Matters | G. Clawson | T. Fox | Samuel S Linton
[1] J. Pollard,et al. Diverse Functions of Macrophages in Different Tumor Microenvironments. , 2018, Cancer research.
[2] W. Xiao,et al. A RIPK3-PGE2 Circuit Mediates Myeloid-Derived Suppressor Cell-Potentiated Colorectal Carcinogenesis. , 2018, Cancer research.
[3] Honglin Li,et al. Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2 , 2018, BMC Cancer.
[4] R. Hoffman,et al. Differential Organ-targeting and Cellular Characteristics of Metastatic Human Pancreatic Cancer Cell Lines in Mouse Models. , 2018, Anticancer research.
[5] K. Lim,et al. Tumor-Stroma IL1β-IRAK4 Feedforward Circuitry Drives Tumor Fibrosis, Chemoresistance, and Poor Prognosis in Pancreatic Cancer. , 2018, Cancer research.
[6] S. Caja,et al. Exosome-Based Cell-Cell Communication in the Tumor Microenvironment , 2018, Front. Cell Dev. Biol..
[7] N. Rothman,et al. Prospective study of urinary prostaglandin E2 metabolite and pancreatic cancer risk , 2017, International journal of cancer.
[8] C. Rao,et al. Loss of natural killer T cells promotes pancreatic cancer in LSL‐KrasG12D/+ mice , 2017, Immunology.
[9] C. Bonifer,et al. Paracrine cyclooxygenase-2 activity by macrophages drives colorectal adenoma progression in the ApcMin/+ mouse model of intestinal tumorigenesis , 2017, Scientific Reports.
[10] R. Brekken,et al. Detection of phosphatidylserine-positive exosomes for the diagnosis of early-stage malignancies , 2017, British Journal of Cancer.
[11] Xiaoqing Pan,et al. IL6 Receptor Blockade Enhances Chemotherapy Efficacy in Pancreatic Ductal Adenocarcinoma , 2017, Molecular Cancer Therapeutics.
[12] T. Whiteside. Exosomes carrying immunoinhibitory proteins and their role in cancer , 2017, Clinical and experimental immunology.
[13] R. Berger,et al. Pancreatic cancer ascites xenograft–an expeditious model mirroring advanced therapeutic resistant disease , 2017, Oncotarget.
[14] S. Dow,et al. Regulation of PD-L1 expression on murine tumor-associated monocytes and macrophages by locally produced TNF-α , 2017, Cancer Immunology, Immunotherapy.
[15] G. Pidgeon,et al. Cross-Talk between Cancer Cells and the Tumour Microenvironment: The Role of the 5-Lipoxygenase Pathway , 2017, International journal of molecular sciences.
[16] D. Curiel,et al. COX2/mPGES1/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells , 2017, Proceedings of the National Academy of Sciences.
[17] P. Nandi,et al. PGE2 promotes breast cancer-associated lymphangiogenesis by activation of EP4 receptor on lymphatic endothelial cells , 2017, BMC Cancer.
[18] D. Mukhopadhyay,et al. Immunosuppressive CD14+HLA-DRlo/neg monocytes are elevated in pancreatic cancer and “primed” by tumor-derived exosomes , 2017, Oncoimmunology.
[19] Joshua M. Weiss,et al. Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis. , 2016, Cancer cell.
[20] M. Lowery,et al. Pancreas Adenocarcinoma: Ascites, Clinical Manifestations, and Management Implications. , 2016, Clinical colorectal cancer.
[21] Y. Chun,et al. Comparative metabolic and lipidomic profiling of human breast cancer cells with different metastatic potentials , 2016, Oncotarget.
[22] M. Amiji,et al. Pancreatic Cancer Cell Exosome-Mediated Macrophage Reprogramming and the Role of MicroRNAs 155 and 125b2 Transfection using Nanoparticle Delivery Systems , 2016, Scientific Reports.
[23] M. Setou,et al. Accumulation of arachidonic acid-containing phosphatidylinositol at the outer edge of colorectal cancer , 2016, Scientific Reports.
[24] A. Schulze,et al. Systematic Analysis Reveals that Cancer Mutations Converge on Deregulated Metabolism of Arachidonate and Xenobiotics. , 2016, Cell reports.
[25] Hai Hu,et al. Sp1 and COX2 expression is positively correlated with a poor prognosis in pancreatic ductal adenocarcinoma , 2016, Oncotarget.
[26] C. Théry,et al. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes , 2016, Proceedings of the National Academy of Sciences.
[27] Hai Hu,et al. The M2 phenotype of tumor-associated macrophages in the stroma confers a poor prognosis in pancreatic cancer , 2016, Tumor Biology.
[28] Gary K. Schwartz,et al. Tumour exosome integrins determine organotropic metastasis , 2015, Nature.
[29] T. Arumugam,et al. Animal Models of Gastrointestinal and Liver Diseases. The difficulty of animal modeling of pancreatic cancer for preclinical evaluation of therapeutics. , 2015, American journal of physiology. Gastrointestinal and liver physiology.
[30] M. Raes,et al. M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide , 2015, BMC Cancer.
[31] Christian Pilarsky,et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer , 2015, Nature.
[32] Michael A. Hollingsworth,et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver , 2015, Nature Cell Biology.
[33] J. Redzic,et al. Examination of the specificity of tumor cell derived exosomes with tumor cells in vitro. , 2014, Biochimica et biophysica acta.
[34] D. Bentrem,et al. TOPIC HIGHLIGHT , 2014 .
[35] R. Andersson,et al. Tumour‐educated macrophages display a mixed polarisation and enhance pancreatic cancer cell invasion , 2014, Immunology and cell biology.
[36] Clotilde Théry,et al. Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles , 2013, Journal of Cell Science.
[37] R. DuBois,et al. An Inflammatory Mediator, Prostaglandin E2, in Colorectal Cancer , 2013, Cancer journal.
[38] R. Hwang,et al. Prostaglandin E2 Regulates Pancreatic Stellate Cell Activity Via the EP4 Receptor , 2013, Pancreas.
[39] M. Zöller,et al. Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection. , 2012, The international journal of biochemistry & cell biology.
[40] A. Durczyński,et al. Prostaglandin E2 (PGE2) in Portal Blood in Patients with Pancreatic Tumor—A Single Institution Series , 2012, Journal of investigative surgery : the official journal of the Academy of Surgical Research.
[41] Y. Daaka,et al. PGE2 promotes angiogenesis through EP4 and PKA Cγ pathway. , 2011, Blood.
[42] L. Daeffler,et al. Pancreatic Cancer Cell Lines Can Induce Prostaglandin E2 Production from Human Blood Mononuclear Cells , 2011, Journal of oncology.
[43] Chengliang Zhang,et al. The TIP30 Protein Complex, Arachidonic Acid and Coenzyme A Are Required for Vesicle Membrane Fusion , 2011, PloS one.
[44] M. Record,et al. Exosomes as intercellular signalosomes and pharmacological effectors. , 2011, Biochemical pharmacology.
[45] A. Mantovani,et al. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm , 2010, Nature Immunology.
[46] Bernard Monsarrat,et al. Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins[S] , 2010, Journal of Lipid Research.
[47] B. Chauffert,et al. Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. , 2010, The Journal of clinical investigation.
[48] A. Molinari,et al. Microenvironmental pH Is a Key Factor for Exosome Traffic in Tumor Cells* , 2009, The Journal of Biological Chemistry.
[49] A. Poliakov,et al. Induction of myeloid‐derived suppressor cells by tumor exosomes , 2009, International journal of cancer.
[50] M. Ahmadi,et al. Prevention of both direct and cross-priming of antitumor CD8+ T-cell responses following overproduction of prostaglandin E2 by tumor cells in vivo. , 2008, Cancer research.
[51] H. Reber,et al. Mononuclear cell-derived interleukin-1 beta confers chemoresistance in pancreatic cancer cells by upregulation of cyclooxygenase-2. , 2008, Surgery.
[52] H. McMahon,et al. Mechanisms of membrane fusion: disparate players and common principles , 2008, Nature Reviews Molecular Cell Biology.
[53] A. Shevchenko,et al. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. , 2008, Journal of lipid research.
[54] H. Suemizu,et al. Identification of a key molecular regulator of liver metastasis in human pancreatic carcinoma using a novel quantitative model of metastasis in NOD/SCID/gammacnull (NOG) mice. , 2007, International journal of oncology.
[55] Li Zhu,et al. Prostaglandin E2 Induces FOXP3 Gene Expression and T Regulatory Cell Function in Human CD4+ T Cells1 , 2005, The Journal of Immunology.
[56] C. Théry,et al. ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming. , 2005, Blood.
[57] Peng Sun,et al. Fusion of Lamellar Body with Plasma Membrane Is Driven by the Dual Action of Annexin II Tetramer and Arachidonic Acid* , 2003, Journal of Biological Chemistry.
[58] M. Tsao,et al. Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma. , 1998, The American journal of pathology.
[59] A. Eklund,et al. Regulated expression of integrins and other adhesion molecules during differentiation of monocytes into macrophages. , 1994, Cellular immunology.
[60] E. Brown,et al. Inhibition of endosome fusion by phospholipase A2 (PLA2) inhibitors points to a role for PLA2 in endocytosis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[61] N. Bhattacharya,et al. An Immunosuppressive Dendritic Cell Subset Accumulates at Secondary Sites and Promotes Metastasis in Pancreatic Cancer. , 2017, Cancer research.
[62] B. Necela,et al. Mutant KRAS-induced expression of ICAM-1 in pancreatic acinar cells causes attraction of macrophages to expedite the formation of precancerous lesions. , 2015, Cancer discovery.
[63] B. Chauffert,et al. Membrane-associated Hsp 72 from tumor-derived exosomes mediates STAT 3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells , 2010 .